CVE-2026-50044: Pronetiqs Panduit Intravue

Medium severity, CVSS 6.8. EPSS: 0.1% chance of exploitation in the next 30 days.

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

Affected products

• Pronetiqs Panduit Intravue: up to and including 3.2.1a14

Published 2026-07-23. Last modified 2026-07-27.